The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study

Completed · Not applicable

Conditions studied: Respiratory Distress Syndrome, Newborn

In brief

The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mechanical ventilation.

Key facts

Study ID

NCT00739115

Run by

Hawaii Pacific Health

People needed

13

Starts

2008-09-01

Expected to finish

2011-08-01

Last updated by the study team

2015-08-26

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gestational age < 33 weeks
• Receiving CPAP from the time of delivery

You may not qualify if…

• Cyanotic congenital heart disease
• Congenital malformation

Where it is running

• Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.